Rona Therapeutics, a biotechnology company pioneering innovative RNA-targeted therapies, announced that the Investigational New Drug (IND)

Avidity Biosciences, Inc. a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates

SparX Biopharmaceutical Corp. announced today that it will present clinical updates on its lead asset, SPX-303, a first-in-class anti-LILRB2/PD-L1 bispecific antibody

Chime Biologics, a leading global CDMO that enables its partners' success in biologics, is pleased to announce a strategic cooperation agreement

Abu Dhabi has cemented its position as a global hub for biotechnology, medical technology and digital health with the opening of a groundbreaking life sciences complex

NLS Pharmaceutics Ltd. a Swiss clinical-stage biopharmaceutical company focused on developing innovative therapies for central nervous system (CNS)

Clarity Pharmaceuticals, a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for patients

A new, mid-size Contract Development Manufacturing Organisation (CDMO), Meribel Pharma Solutions has launched today with an extensive integrated network

Accord BioPharma, Inc., the U.S. specialty division of Intas Pharmaceuticals, Ltd., focused on the development of oncology, immunology, and critical care therapies

PRISM BioLab, Co. Ltd. a leading discovery and development biotechnology company designing small molecule inhibitors of protein-protein interaction